EverHint – EMA 10/30 Crossover, EMA 10 + Price + MACD, SMA 20/50 Crossover – Top 30 Buy and Top 10 Sell Signals for Oct 20, 2026
Excerpt: 40 signals (from 152 total). Healthcare leads (36). price range $5-$535. 7 with insider selling.
EMA 10/30 Crossover
Detects fresh crossovers between the 10-day exponential moving average (EMA10) and the 30-day exponential moving average (EMA30), generating both buy and sell signals. Uses two EMAs instead of EMA + SMA, making it more responsive to price changes and better suited for capturing short-to-medium term momentum shifts.
Entry Criteria:
- Buy: EMA10 crosses above EMA30
- Sell: EMA10 crosses below EMA30
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 1-4 weeks | Risk level: Medium
🟢 Buy Signals (10 of 65)
Ranked by RSI (lower RSI for buy signals = more oversold)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | AGIO | Agios Pharmaceuticals,... | Healthcare | $36.64 | — | $2.2B |
| 2 | AHR | American Healthcare RE... | Real Estate | $54.35 | — | $11.8B |
| 3 | ALL | The Allstate Corporation | Financial Services | $249.90 | — | $63.2B |
| 4 | ALLE | Allegion plc | Industrials | $157.06 | — | $13.4B |
| 5 | AMCR | Amcor plc | Consumer Cyclical | $44.73 | — | $20.7B |
| 6 | AOS | A. O. Smith Corporation | Industrials | $59.54 | — | $8.1B |
| 7 | ATAT | Atour Lifestyle Holdin... | Consumer Cyclical | $33.35 | — | $4.6B |
| 8 | AWI | Armstrong World Indust... | Industrials | $169.51 | — | $7.2B |
| 9 | AZN | AstraZeneca PLC | Healthcare | $168.82 | — | $261.8B |
| 10 | BAH | Booz Allen Hamilton Ho... | Industrials | $74.97 | — | $9.0B |
🔴 Sell Signals (5 of 24)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | AER | AerCap Holdings N.V. | Industrials | $144.46 | — | $22.7B |
| 2 | AMD | Advanced Micro Devices... | Technology | $534.74 | — | $872.9B |
| 3 | ARW | Arrow Electronics, Inc. | Technology | $214.93 | — | $10.9B |
| 4 | BIRK | Birkenstock Holding plc | Consumer Cyclical | $32.78 | — | $5.8B |
| 5 | CEG | Constellation Energy C... | Utilities | $258.84 | — | $91.7B |
EMA 10 + Price + MACD
Experimental strategy combining price crossing above EMA10 from below with MACD Line crossing above Signal Line from below. Both conditions must occur on the same day for a signal, providing double confirmation and higher-quality setups.
Entry Criteria:
- Buy: Price > EMA10 AND MACD line crosses above signal line
- Sell: Price < EMA10 AND MACD line crosses below signal line
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh signal: All conditions met on today's close
Holding period: 1-3 weeks | Risk level: Medium-High
🟢 Buy Signals (10 of 44)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | AMLX | Amylyx Pharmaceuticals... | Healthcare | $28.77 | — | $3.6B |
| 2 | APAM | Artisan Partners Asset... | Financial Services | $32.96 | — | $2.3B |
| 3 | AVNT | Avient Corporation | Basic Materials | $40.35 | — | $3.7B |
| 4 | BKU | BankUnited, Inc. | Financial Services | $42.32 | — | $3.0B |
| 5 | BMRN | BioMarin Pharmaceutica... | Healthcare | $56.44 | — | $10.9B |
| 6 | BOKF | BOK Financial Corporation | Financial Services | $126.46 | — | $7.7B |
| 7 | COLD | Americold Realty Trust... | Real Estate | $14.10 | — | $4.0B |
| 8 | CRL | Charles River Laborato... | Healthcare | $315.45 | — | $15.2B |
| 9 | CWK | Cushman & Wakefield plc | Real Estate | $11.51 | — | $2.7B |
| 10 | DK | Delek US Holdings, Inc. | Energy | $77.63 | — | $4.8B |
SMA 20/50 Crossover
Detects fresh crossovers between the 20-day simple moving average (SMA20) and the 50-day simple moving average (SMA50). Uses two SMAs, making it more stable and less prone to false signals compared to EMA-based strategies. Well-suited for identifying medium-term trend changes with higher reliability.
Entry Criteria:
- Buy: SMA20 crosses above SMA50
- Sell: SMA20 crosses below SMA50
- Minimum ADV: $40M (liquidity filter)
- Earnings buffer: 7 days pre/post earnings
- Fresh crossover: Detected on today's close
Holding period: 2-6 weeks | Risk level: Medium
🟢 Buy Signals (10 of 14)
Ranked by RSI (lower RSI = more oversold for buy signals)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | AMGN | Amgen Inc. | Healthcare | $438.94 | — | $237.3B |
| 2 | ASAN | Asana, Inc. | Technology | $10.74 | — | $2.5B |
| 3 | BTE | Baytex Energy Corp. | Energy | $5.37 | — | $3.8B |
| 4 | CAH | Cardinal Health, Inc. | Healthcare | $257.55 | — | $59.6B |
| 5 | CME | CME Group Inc. | Financial Services | $295.31 | — | $106.2B |
| 6 | DGII | Digi International Inc. | Technology | $74.73 | — | $2.8B |
| 7 | DIS | The Walt Disney Company | Communication Services | $111.66 | Sell -$318,958 | $192.8B |
| 8 | EOG | EOG Resources, Inc. | Energy | $157.91 | — | $82.8B |
| 9 | GGG | Graco Inc. | Industrials | $81.09 | — | $13.1B |
| 10 | HAS | Hasbro, Inc. | Consumer Cyclical | $109.52 | — | $15.4B |
🔴 Sell Signals (5 of 5)
| # | Ticker | Company | Sector | Price | Insider | MCap |
|---|---|---|---|---|---|---|
| 1 | AUGO | Aura Minerals | Basic Materials | $84.25 | — | $7.1B |
| 2 | MRK | Merck & Co., Inc. | Healthcare | $148.30 | — | $365.9B |
| 3 | NEO | NeoGenomics, Inc. | Healthcare | $16.62 | — | $2.2B |
| 4 | PSNL | Personalis, Inc. | Healthcare | $15.94 | — | $1.7B |
| 5 | SITM | SiTime Corporation | Technology | $497.11 | — | $14.9B |
Insider selling (7d): DIS (-$318,958)
Recent Headlines
ALL (The Allstate Corporation)
- Allstate (ALL) Outpaces Stock Market Gains: What You Should Know
AMD (Advanced Micro Devices, Inc.)
- OpenAI Is Reportedly Raising $30 Billion. Which Chip Stock Gains the Most?
CAH (Cardinal Health, Inc.)
- Cardinal Health (CAH) Laps the Stock Market: Here's Why
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Enjoying the updates? Liking, sharing, or subscribing helps bring this analysis to a wider audience.